Skip to main content
The Association of British Clinical Diabetologists
User account menu
Back to the ABCD Home page
Become a member
Log in
Main navigation
About
Reach and Representation
Committee
Member Memorial
Overview
Professional Development
Consultant Development Programme
Personal Development
Diabetes & Endocrine Trainees
Mentorship
Overview
Events
Submit an Abstract
Webinars
Event Archive
Event Terms and Conditions
Overview
Resources
Position Papers and Guidelines
Joint British Diabetes Societies
Rowan Hillson Awards
Overview
Audits
ABCD Closed-Loop Audit
ABCD NHS England Nationwide Closed Loop Pilot Audit
ABCD Dexcom Audit
ABCD FreeStyle Libre Audit
ABCD Testosterone & Diabetes Worldwide Audit
ABCD Oral Semaglutide Audit
ABCD Semaglutide Audit
ABCD EndoBarrier Worldwide Registry
ABCD and Sanofi DKA Collaborative Working Project
Audit Publications
Grants
Diabetes Dragons' Den
Research Grants
Travel Grants
Overview
DTN-UK
About DTN-UK
Join the Diabetes Technology Network UK (DTN-UK)
Videos
Resources
Events
Best Practice Guides and Top Tips
Links to HCP education resources
Committee
Overview
British Journal of Diabetes
Search
Search the Association of British Clinical Diabetologists
Search
Breadcrumb
Home
Treatments For Diabetes
Treatments for diabetes
More patients achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg systolic blood pressure with semaglutide versus comparators (SUSTAIN 1–5, 7)
Resource
Taxonomy
Abstracts
Current
Diabetes
Treatments for diabetes
Event resources
Bridging The Gap: Piloting Integrated Clinical Health Psychology and Young Adult Diabetes Services in Wrexham
Resource
Taxonomy
Abstracts
Current
Diabetes
Treatments for diabetes
Event resources
Impact of Background Antihyperglycaemic Therapy on Insulin Glargine 300 U/mL (Gla-300) vs Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve People with T2DM from the BRIGHT Randomised Study
Resource
Taxonomy
Abstracts
Current
Diabetes
Treatments for diabetes
Type 2 diabetes mellitus
Event resources
Similar Variability of Fasting and 24-h Self-Measured Plasma Glucose (SMPG) with Insulin Glargine 300 U/mL (Gla-300) vs Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve Adults with T2DM: the Randomised BRIGHT Trial
Resource
Taxonomy
Abstracts
Current
Diabetes
Treatments for diabetes
Type 2 diabetes mellitus
Event resources
Physician perception and clinical practise regarding use of SGLT2 inhibitors in patients with foot ulcer disease
Resource
Taxonomy
Abstracts
Current
Diabetes
Treatments for diabetes
Event resources
More patients achieved composite reductions of ≥1% HbA1c, ≥5% body weight and ≥5 mmHg systolic blood pressure with semaglutide versus comparators (SUSTAIN 1–5, 7)
Resource
Taxonomy
Current
Diabetes
Obesity
Treatments for diabetes
Posters
Event resources
Bridging The Gap: Piloting Integrated Clinical Health Psychology and Young Adult Diabetes Services in Wrexham
Resource
Taxonomy
Current
Diabetes
Juvenile diabetes
Treatments for diabetes
Posters
Event resources
Impact of background antihyperglycemic therapy on insulin glargine 300 U/ml (Gla-300) vs insulin degludec 100 U/ml (IDeg-100) in insulin naive people with T2DM from BRIGHT randomised study
Resource
Taxonomy
Current
Diabetes
Treatments for diabetes
Type 2 diabetes mellitus
Posters
Event resources
Similar variability of fasting and 24-h self-measured plasma glucose (SMPG) with insuling glargine 300 U/ml (Gla-300) vs insulin degludec 100/ml (IDeg-100) in insulin-naive adults with T2DM: the randomised BRIGHT trial
Resource
Taxonomy
Current
Diabetes
Treatments for diabetes
Posters
Event resources
Reduction in systolic blood pressure (SBP) with semaglutide treatment is not due to weight loss (WL) alone: data from SUSTAIN
Resource
Taxonomy
Abstracts
Current
Diabetes
Treatments for diabetes
Event resources
ABCD Nationwide Semaglutide Audit
Resource
Taxonomy
Audit
Current
Diabetes
Treatments for diabetes
Slides
Event resources
ABCD audits update
Resource
Taxonomy
Audit
Current
Diabetes
Treatments for diabetes
Slides
Event resources
Pagination
First
Previous
…
Page
42
Page
43
Page
44
Page
45
46
Page
47
Page
48
Page
49
Page
50
Next
Last
Subscribe to The Association of British Clinical Diabetologists
Main navigation
About
Reach and Representation
Committee
Member Memorial
Overview
Professional Development
Consultant Development Programme
Personal Development
Diabetes & Endocrine Trainees
Mentorship
Overview
Events
Submit an Abstract
Webinars
Event Archive
Event Terms and Conditions
Overview
Resources
Position Papers and Guidelines
Joint British Diabetes Societies
Rowan Hillson Awards
Overview
Audits
ABCD Closed-Loop Audit
ABCD NHS England Nationwide Closed Loop Pilot Audit
ABCD Dexcom Audit
ABCD FreeStyle Libre Audit
ABCD Testosterone & Diabetes Worldwide Audit
ABCD Oral Semaglutide Audit
ABCD Semaglutide Audit
ABCD EndoBarrier Worldwide Registry
ABCD and Sanofi DKA Collaborative Working Project
Audit Publications
Grants
Diabetes Dragons' Den
Research Grants
Travel Grants
Overview
DTN-UK
About DTN-UK
Join the Diabetes Technology Network UK (DTN-UK)
Videos
Resources
Events
Best Practice Guides and Top Tips
Links to HCP education resources
Committee
Overview
British Journal of Diabetes
Search
Search the Association of British Clinical Diabetologists
Search
User account menu
Back to the ABCD Home page
Become a member
Log in